Medication-assisted treatment of opioid use disorder: review of the evidence and future directions

Harvard Review of Psychiatry
Hilary Smith Connery

Abstract

Medication-assisted treatment of opioid use disorder with physiological dependence at least doubles rates of opioid-abstinence outcomes in randomized, controlled trials comparing psychosocial treatment of opioid use disorder with medication versus with placebo or no medication. This article reviews the current evidence for medication-assisted treatment of opioid use disorder and also presents clinical practice imperatives for preventing opioid overdose and the transmission of infectious disease. The evidence strongly supports the use of agonist therapies to reduce opioid use and to retain patients in treatment, with methadone maintenance remaining the gold standard of care. Combined buprenorphine/naloxone, however, also demonstrates significant efficacy and favorable safety and tolerability in multiple populations, including youth and prescription opioid-dependent individuals, as does buprenorphine monotherapy in pregnant women. The evidence for antagonist therapies is weak. Oral naltrexone demonstrates poor adherence and increased mortality rates, although the early evidence looks more favorable for extended-release naltrexone, which has the advantages that it is not subject to misuse or diversion and that it does not present ...Continue Reading

References

Mar 9, 2000·Addiction·J M White, R J Irvine
Oct 12, 2001·JAMA : the Journal of the American Medical Association·D A FiellinR S Schottenfeld
Jan 5, 2002·The American Journal of Psychiatry·Thomas R Kosten, David A Gorelick
May 2, 2002·The Australian and New Zealand Journal of Psychiatry·Alison J Ritter
Sep 5, 2003·The New England Journal of Medicine·Paul J FudalaUNKNOWN Buprenorphine/Naloxone Collaborative Study Group
Apr 7, 2005·JAMA : the Journal of the American Medical Association·James C GarbuttUNKNOWN Vivitrex Study Group
Oct 6, 2005·Archives of General Psychiatry·Lisa A MarschJohn Brooklyn
Mar 31, 2006·Psychopharmacology·Gisela GreckschThomas Koch
May 17, 2006·Journal of Clinical Psychopharmacology·Nicholas LintzerisJohn Strang
Oct 3, 2006·Psychopharmacology·Christopher J CorreiaEric C Strain
Jun 15, 2007·Drug and Alcohol Review·Amy E Gibson, Louisa J Degenhardt
Jul 24, 2007·Drug and Alcohol Dependence·Elinore F McCance-KatzPetrie M Rainey
Sep 18, 2007·Journal of Clinical Psychopharmacology·Stephanie S O'MalleyHenry R Kranzler
Sep 9, 2008·Annals of Emergency Medicine·J Elise BaileyUNKNOWN RADARS System Poison Center Investigators
Nov 6, 2008·JAMA : the Journal of the American Medical Association·George E WoodyPaul Fudala
Nov 21, 2009·Clinical Psychology Review·Jennifer C VeilleuxAdrienne J Heinz
Apr 16, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Christina S MeadeGeorge E Woody
Oct 6, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Ernest V Pedapati, Scot T Bateman
Oct 14, 2010·JAMA : the Journal of the American Medical Association·Walter LingKatherine L Beebe
Dec 21, 2010·Journal of Addiction Medicine·Michael P BogenschutzGeorge E Woody
Jan 11, 2011·Regulatory Toxicology and Pharmacology : RTP·Donna A VolpeS Leigh Verbois
May 21, 2011·Drug and Alcohol Dependence·Elinore F McCance-KatzPetrie M Rainey
Jul 1, 2011·Drug and Alcohol Dependence·Adam BisagaEdward V Nunes
Mar 13, 2012·The American Journal of Drug and Alcohol Abuse·Stacey C SigmonGeorge Woody
May 26, 2012·Addictive Behaviors·Diane WardenMadhukar H Trivedi
Jun 30, 2012·BMC Public Health·Perrine RouxUNKNOWN ANRS Methaville Study Group
Aug 10, 2012·Journal of Addictive Diseases·Gavin Bart
Aug 28, 2012·Drug and Alcohol Dependence·Andrew J SaxonPetra Jacobs
Sep 18, 2012·Journal of Substance Abuse Treatment·Alexander Y WalleyAl Ozonoff

❮ Previous
Next ❯

Citations

Mar 14, 2016·Journal of Substance Abuse Treatment·Lisa J MerloRobert L DuPont
Feb 28, 2016·Journal of Substance Abuse Treatment·Michael D SteinBradley J Anderson
Jul 28, 2015·Preventive Medicine·Marjorie Meyer, Julie Phillips
Jul 22, 2016·The American Journal on Addictions·David E MarcovitzHilary S Connery
Jan 31, 2017·Journal of Psychosocial Nursing and Mental Health Services·Laura G Leahy
Jun 3, 2017·Expert Review of Clinical Pharmacology·Steven ChavoustieVictoria Sanjurjo
Oct 11, 2017·Scandinavian Journal of Pain·Kehua ZhouGary G Wang
Feb 6, 2018·Addiction·Brantley P JarvisKenneth Silverman
Jan 6, 2018·The Annals of Pharmacotherapy·Natalia ShcherbakovaRobert J Roose
Mar 30, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Sharon LevyJonas Bromberg
Apr 7, 2018·Pain and Therapy·Edward A ShiptonAshleigh J Shipton
Feb 13, 2018·Journal of Addiction Medicine·Jacob T BorodovskyLisa A Marsch
Jun 7, 2018·Alcoholism, Clinical and Experimental Research·Katie WitkiewitzHenry R Kranzler
May 19, 2018·Current HIV/AIDS Reports·Katherine M RichJudith Feinberg
Sep 29, 2018·The American Journal on Addictions·Eric WeintraubChristopher Welsh
Jun 12, 2018·Journal of Addiction Medicine·Madeline C FrostCaleb J Banta-Green
Dec 19, 2018·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Taeho Greg Rhee
Feb 28, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Namkee G ChoiBryan Y Choi
Mar 5, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Gerrit PrinslooM Eugenia Socías
Feb 23, 2019·Orthopaedic Nursing·Susan SalmondRobert Marsh
Oct 1, 2019·Journal of Hospice and Palliative Nursing : JHPN : the Official Journal of the Hospice and Palliative Nurses Association·Katie Fitzgerald Jones
Oct 17, 2019·Journal of Pain & Palliative Care Pharmacotherapy·Gary HouchardStephanie Abel
Dec 11, 2019·Journal of Addictive Diseases·Phillip L MarottaNabila El-Bassel
Apr 26, 2019·International Journal of Circumpolar Health·Rosalyn SingletonEvelyn Rider
Dec 21, 2019·Substance Use & Misuse·Devon Meadowcroft, Brian Whitacre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
Cindy Parks ThomasMiriam E Delphin-Rittmon
European Review for Medical and Pharmacological Sciences
F CurcioGruppo Responsabili UO Sert T
Substance Abuse : Research and Treatment
Kimberly L Kjome, F Gerard Moeller
© 2022 Meta ULC. All rights reserved